Abstract
Efficacy and safety of first-line TKI plus ICI therapy in metastatic non-clear cell renal cell carcinoma: A real-world multiple-centre study.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have